Claudia Schmoor

Stefan Meier Str. 26
Freiburg, BW 79104, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 101 publications

DECIDER-2: Prospective randomized multicenter phase III trial of decitabine and venetoclax administered in combination with all-trans retinoic acid or placebo in patients with acute myeloid leukemia who are ineligible for induction chemotherapy.

DECIDER-2: Prospective randomized multicenter phase III trial of decitabine and venetoclax administered in combination with all-trans retinoic acid or placebo in patients with acute myeloid leukemia who are ineligible for induction chemotherapy.

Journal: BMC cancer

Published: June 16, 2026

Reply to: Quality of Chemoradiotherapy in Esophageal Adenocarcinoma Matters.

Reply to: Quality of Chemoradiotherapy in Esophageal Adenocarcinoma Matters.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: March 05, 2026

Support for Patient-Centered Cardiovascular Risk Counseling With Two Components of the DECADE Intervention: Findings of a Multiregional, Cluster-Randomized Controlled Trial.

Support for Patient-Centered Cardiovascular Risk Counseling With Two Components of the DECADE Intervention: Findings of a Multiregional, Cluster-Randomized Controlled Trial.

Journal: Deutsches Arzteblatt international

Published: November 07, 2025

Response to van Rossum et al.: contextualizing ESOPEC in the evolving landscape of esophageal adenocarcinoma therapy.

Response to van Rossum et al.: contextualizing ESOPEC in the evolving landscape of esophageal adenocarcinoma therapy.

Journal: Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus

Published: November 05, 2025

Recurrence Patterns of Esophageal Adenocarcinoma in the Phase III ESOPEC Trial Comparing Perioperative Chemotherapy With Preoperative Chemoradiotherapy.

Recurrence Patterns of Esophageal Adenocarcinoma in the Phase III ESOPEC Trial Comparing Perioperative Chemotherapy With Preoperative Chemoradiotherapy.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: July 09, 2025

Perioperative Chemotherapy in Esophageal Cancer. Reply.

Perioperative Chemotherapy in Esophageal Cancer. Reply.

Journal: The New England journal of medicine

Published: April 16, 2025

Sensitization of Non-M3 Acute Myeloid Leukemia Blasts to All-Trans Retinoic Acid by the LSD1 Inhibitor Tranylcypromine: TRANSATRA Phase I Study.

Sensitization of Non-M3 Acute Myeloid Leukemia Blasts to All-Trans Retinoic Acid by the LSD1 Inhibitor Tranylcypromine: TRANSATRA Phase I Study.

Journal: European journal of haematology

Published: February 17, 2025

Perioperative Chemotherapy or Preoperative Chemoradiotherapy in Esophageal Cancer.

Perioperative Chemotherapy or Preoperative Chemoradiotherapy in Esophageal Cancer.

Journal: The New England journal of medicine

Published: January 22, 2025

Nurses' Perspectives and Experiences of Using a Bed-Exit Information System in an Acute Hospital Setting: Mixed Methods Study.

Nurses' Perspectives and Experiences of Using a Bed-Exit Information System in an Acute Hospital Setting: Mixed Methods Study.

Journal: JMIR formative research

Published: July 28, 2024

Hazards Constitute Key Quantities for Analyzing, Interpreting and Understanding Time-to-Event Data.

Hazards Constitute Key Quantities for Analyzing, Interpreting and Understanding Time-to-Event Data.

Journal: Biometrical journal. Biometrische Zeitschrift

Published: June 28, 2024

Continued decitabine/all-trans retinoic acid treatment: extended complete remission in an elderly AML patient with multi-hit TP53 lesions and complex-monosomal karyotype.

Continued decitabine/all-trans retinoic acid treatment: extended complete remission in an elderly AML patient with multi-hit TP53 lesions and complex-monosomal karyotype.

Journal: Clinical epigenetics

Published: June 07, 2024

Impact of TP53 Mutation Status in Elderly AML Patients When Adding All-Trans Retinoic Acid or Valproic Acid to Decitabine.

Impact of TP53 Mutation Status in Elderly AML Patients When Adding All-Trans Retinoic Acid or Valproic Acid to Decitabine.

Journal: European journal of haematology

Published: May 27, 2024

Showing 1-12 of 101

Last Updated: 09/26/2026